| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.236 | 53.802 | 127.022 | 100.124 | 142.978 | 59.700 | 111.358 | 103.683 | 227.754 | 1.716 |
| Total Income - EUR | 30.236 | 53.827 | 127.197 | 100.186 | 176.158 | 89.579 | 111.381 | 128.628 | 227.788 | 73.603 |
| Total Expenses - EUR | 24.941 | 34.710 | 42.478 | 125.122 | 102.186 | 89.657 | 46.783 | 58.784 | 161.162 | 104.904 |
| Gross Profit/Loss - EUR | 5.295 | 19.117 | 84.719 | -24.936 | 73.972 | -78 | 64.599 | 69.844 | 66.626 | -31.301 |
| Net Profit/Loss - EUR | 4.388 | 17.869 | 82.898 | -25.938 | 72.211 | -923 | 63.507 | 68.584 | 64.394 | -32.336 |
| Employees | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Yellow Farmagram S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.270 | 21.663 | 44.954 | 63.422 | 65.317 | 49.163 | 42.069 | 45.920 | 90.228 | 117.079 |
| Current Assets | 1.643 | 34.207 | 56.654 | 5.424 | 44.798 | 51.130 | 69.750 | 112.553 | 109.475 | 32.769 |
| Inventories | 0 | 0 | 42.706 | 0 | 0 | 0 | 0 | 40.708 | 0 | 13.423 |
| Receivables | 1.494 | 25.365 | 2.790 | 2.184 | 44.643 | 8.332 | 3.069 | 64.470 | 108.366 | 47.953 |
| Cash | 148 | 8.843 | 11.158 | 3.239 | 155 | 42.798 | 66.682 | 7.376 | 1.109 | -28.607 |
| Shareholders Funds | 4.442 | 17.923 | 82.950 | -25.886 | 46.826 | -873 | 62.653 | 68.632 | 81.848 | -32.287 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.511 | 37.948 | 18.658 | 89.365 | 80.020 | 105.318 | 51.566 | 93.202 | 117.855 | 182.192 |
| Income in Advance | 0 | 0 | 0 | 6.501 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Yellow Farmagram S.r.l.